Related Experiment Videos
Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics
1Neurobiology Division, Fondax, Puteaux, France.
Abstract:
Methylphenidate (MPD) increased in rats the incidence of sniffing, rearing and locomotion, and this along dose-response curves that had an inverted U-shape; at 40 mg/kg, MPD exclusively induced stereotyped gnawing, which was inhibited by neuroleptics. However, as gnawing induced by 40 mg/kg MPD was inhibited in a dose-dependent manner, other responses (i.e., sniffing, rearing and locomotion) appeared. Higher doses of neuroleptics also inhibited these latter responses, so that the behavior of the MPD-treated animals became similar to that of normal controls. Only some nonsedative neuroleptics appeared able to normalize the behavior of MPD-treated rats at doses that induced neither complete behavioral suppression nor adverse effects. The neuroleptics differed markedly, however, in terms of the relative doses at which they 1) inhibited gnawing, 2) inhibited the other effects of MPD and 3) induced complete behavioral suppression and/or adverse effects. This variation among neuroleptics, which appears to represent a novel aspect of their ability to antagonize behavioral effects of central nervous system stimulants, may be based on differences in the extent to which they exert agonist activity at dopamine receptors. Assuming that MPD-induced behaviors model the positive symptoms of schizophrenia, it may be hypothesized that the differences among the neuroleptics observed here provide an indication of their efficacy to reduce positive symptoms in schizophrenics.
Insights
Methylphenidate (MPD) in rats caused dose-dependent behavioral changes, including stereotyped gnawing. Neuroleptics differentially reversed these effects, suggesting potential efficacy in treating schizophrenia symptoms.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Methylphenidate (MPD) is a central nervous system stimulant.
- MPD's behavioral effects in rats exhibit an inverted U-shaped dose-response curve.
- Neuroleptics are used to manage certain behavioral disorders.
Purpose of the Study:
- To investigate the dose-dependent effects of methylphenidate (MPD) on rat behavior.
- To examine the efficacy of various neuroleptics in antagonizing MPD-induced behaviors.
- To explore the potential of these findings for understanding neuroleptic treatment in schizophrenia.
Main Methods:
- Administered varying doses of methylphenidate (MPD) to rats.
- Observed and quantified behavioral responses such as sniffing, rearing, locomotion, and gnawing.
- Administered different neuroleptics to assess their effects on MPD-induced behaviors.
- Analyzed dose-response relationships and differential effects of neuroleptics.
Main Results:
- MPD increased sniffing, rearing, and locomotion in an inverted U-shaped dose-response manner.
- At 40 mg/kg, MPD specifically induced stereotyped gnawing, which was antagonized by neuroleptics.
- Neuroleptics differentially inhibited MPD-induced behaviors, with some nonsedative agents normalizing behavior without adverse effects.
- Variations in neuroleptic efficacy may relate to dopamine receptor activity.
Conclusions:
- Neuroleptics exhibit differential abilities to antagonize MPD-induced behaviors in rats.
- The observed variations suggest a novel mechanism for neuroleptic action against stimulant effects.
- Findings provide a potential preclinical model for predicting neuroleptic efficacy in reducing positive symptoms of schizophrenia.